Buybacks have gotten a bad rap from both Republicans and Democrats. But stocks would be trading at a massive discount without them.Marketsread more
The biggest U.S. gasoline price surge in years is running out of steam just in time for the start of the summer driving season.Energyread more
Stocks rose on Friday, but notched weekly losses as investors worried the U.S.-China trade war is hurting economic growth.US Marketsread more
The combination of mounting recession fears, bets on a more cautious Fed and a regular uptick in market volatility could spell more losses.Marketsread more
The therapy, Zolgensma, is a one-time treatment for spinal muscular atrophy — a muscle-wasting disease and leading genetic cause of infant mortality, affecting 1 in every...Biotech and Pharmaceuticalsread more
SpaceX has raised just over $1 billion in financing since the beginning of the year.Investing in Spaceread more
An analyst for Ark Invest, which has a major investment in Tesla, says recent drastic price-target cuts by others on Wall Street are missing the big picture.Investingread more
A federal judge in California has blocked President Donald Trump from building sections of his long-sought border wall with money secured under his declaration of a national...Politicsread more
Former Foreign Minister Boris Johnson is seen as the bookmaker's favorite to succeed outgoing Prime Minister Theresa May.Europe Politicsread more
The race is underway to find a vaccine that can control African swine fever, a highly contagious and deadly viral infection ravaging China's hog population. There is currently...Agricultureread more
Shares of Chemours recovered from a steep decline after short-seller Citron Research released a report calling the U.S.-based chemical firm "a zero."
"Highly material events for Chemours are unfolding nearly every day in the matter of DuPont's liabilities due to its manufacturing of C8 — also known as PFOA, and its 60 year pattern of willfully hiding its knowledge that the chemical was toxic at extremely low levels of exposure, and was being dumped into the environment at its facilities. DuPont dumped these liabilities into spin-off Chemours, " Citron said in its report. "But don't count on Chemours to disclose these material events."
Chemours' stock fell as much as 9 percent in Thursday's trading session, before recovering to close more than half a percent higher. Chemours did not immediately respond to CNBC's request for comment.
Greenlight Capital, the hedge fund run by David Einhorn, raised its stake in the Chemours by 5.44 million shares to 8.84 million, according to a recent 13F filing. Greenlight did not immedately respond to CNBC's request for comment.
CC intradaySource: FactSet